Our research shows that IL-33/ST2 protein levels are elevated after ischemia, accompanied by astrocyte and microglia activation, and this trend was reduced by both iPSC-EVs and EA treatment, whereas a more significant decrease in these levels was observed in the EA+iPSC-EVs group. The gene discussed is IL33; the disease is ischemia.